M

Molecular Sensing, Inc.

50 employees

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Collaboration
Medical
Bioanalytical & Diagnostic Instrumentation Commercialization and Drug Discovery Collaboration Services

Date founded

2007

Funding rounds raised

Total raised

$2.7M

from 15 investors over 15 rounds

M

Molecular Sensing, Inc. raised undisclosed on April 3, 2020

Investors: LaunchTN

M

Molecular Sensing, Inc. raised $250K on January 29, 2016

Investors: Cultivation Capital

M

Molecular Sensing, Inc. raised $500K on August 18, 2014

Investors: Cultivation Capital

M

Molecular Sensing, Inc. raised $2.7M on July 23, 2014

Investors: LaunchTN, Tri-Star Health Partners and Cultivation Capital

M

Molecular Sensing, Inc. raised $1.5M on November 15, 2013

Investors: Tri-Star Health Partners and LaunchTN

M

Molecular Sensing, Inc. raised $450K on September 1, 2013

Investors: Tri-Star Health Partners and LaunchTN

M

Molecular Sensing, Inc. raised $100K on June 1, 2013

Investors: Tri-Star Health Partners

M

Molecular Sensing, Inc. raised $1.4M on June 1, 2012

Investors: Tri-Star Health Partners and LaunchTN

M

Molecular Sensing, Inc. raised $125K on March 1, 2012

Investors: Tri-Star Health Partners

M

Molecular Sensing, Inc. raised $1M on November 1, 2011

Investors: Tri-Star Health Partners

FAQ